BIOPOL CHEMICALS LIMITED (BIOPOL-SM) Share Price Surges 12.54% Today

BIOPOL CHEMICALS LIMITED Share Price rises 12.54% today, reaching Rs 109.5 with a market cap of Rs 105.14 Cr.

BIOPOL CHEMICALS LIMITED Share Price has experienced a significant surge today, rising by 12.54% to reach Rs 109.5. This impressive gain positions the company as a top gainer in the micro cap category, with a market capitalisation of Rs 105.14 crore. The stock opened at Rs 96 and quickly climbed to a high of Rs 109.95, demonstrating strong investor interest and trading activity.

The price rise of BIOPOL CHEMICALS LIMITED is noteworthy as it surpasses the qualifying threshold of 8.1% set for its market-cap category. This movement highlights the stock's potential within the Chemicals sector, drawing attention from investors and analysts alike. While the data confirms the price event, it does not establish a specific company-related catalyst for today's rally.

BIOPOL CHEMICALS LIMITED Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 109.5
Previous Close	Rs 97.3
Today's Change	+Rs 12.2 (+12.54%)
Day Open	Rs 96
Day High	Rs 109.95
Day Low	Rs 95.5
Current Volume (NSE)	1,28,400
NSE Traded Volume	1,28,400
Combined NSE + BSE Volume	1,28,400
Turnover	Rs 1.41 crore
Market Capitalisation	Rs 105.14 crore
Market Cap Category	Micro Cap
Qualifying Threshold Cleared	8.1%

Today, BIOPOL CHEMICALS LIMITED's share price opened at Rs 96 and reached a high of Rs 109.95, closing at Rs 109.5. The previous close was Rs 97.3, marking a day change of Rs 12.2 and a percentage increase of 12.54%. The stock's turnover stood at Rs 1.41 crore, with a total volume of 1,28,400 shares traded on the NSE.

This price action places BIOPOL CHEMICALS LIMITED in the micro cap category, where it exceeded the qualifying threshold of 8.1%. The significant volume and turnover indicate robust market participation, reflecting heightened interest in the stock. The day's low was recorded at Rs 95.5, showcasing the stock's volatility and investor engagement throughout the trading session.

The notable price movement and trading volume suggest that BIOPOL CHEMICALS LIMITED is capturing market attention, making it a stock to watch closely. As we delve into the technical analysis, the focus will shift to understanding the momentum and potential future trends.

BIOPOL CHEMICALS LIMITED Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 105.14 crore
P/E Ratio	11.71x
P/B Ratio	2.11x
ROE	13.92%
ROCE	14.37%
EPS	Rs 8.31
Book Value Per Share	Rs 46.2
Dividend Yield	0%

BIOPOL CHEMICALS LIMITED was valued at a P/E ratio of 11.71x, a P/B ratio of 2.11x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.

Profitability and capital efficiency were represented by ROE of 13.92% and ROCE of 14.37%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.

Per-share and shareholder-return metrics included EPS of Rs 8.31, book value per share of Rs 46.2, dividend yield of 0%. Dividend yield is a current or historical ratio and does not guarantee future distributions.

BIOPOL CHEMICALS LIMITED, with a market capitalisation of Rs 105.14 crore, presents an intriguing case for fundamental analysis. The company's P/E ratio stands at 11.71, which is below the industry median of 18.07, indicating a potentially undervalued position relative to its peers. The P/B ratio of 2.11, however, is above the industry median of 1.58, suggesting a higher valuation on a book value basis.

The company's return on equity (ROE) is 13.92%, slightly above the industry median of 12.43%, reflecting efficient use of shareholder funds. The return on capital employed (ROCE) is 14.37%, which is marginally below the industry median of 14.92%. These metrics highlight the company's ability to generate returns on its investments.

With an earnings per share (EPS) of Rs 8.31 and a book value of Rs 46.2, BIOPOL CHEMICALS LIMITED demonstrates solid earnings and asset backing. The absence of a dividend yield indicates that the company may be reinvesting profits for growth rather than distributing them to shareholders. These fundamentals provide a comprehensive view of the company's financial health and valuation in the context of the Chemicals sector.

Sector and Industry Context

Metric	Value
Sector	Chemicals
Industry	Chemicals
Benchmark Scope	same industry
Companies in Benchmark	139
Company P/E Ratio	11.71x
Benchmark Median P/E	18.07x
Benchmark Average P/E	48.83x
Benchmark P/E Range	0x to 890.11x
Companies with P/E Data	139
Company P/B Ratio	2.11x
Benchmark Median P/B	1.58x
Company ROE	13.92%
Benchmark Median ROE	12.43%
Company ROCE	14.37%
Benchmark Median ROCE	14.92%
Company Market Capitalisation	Rs 105.14 crore
Benchmark Median Market Cap	Rs 226.81 crore

BIOPOL CHEMICALS LIMITED (BIOPOL-SM) is classified under sector: Chemicals and industry: Chemicals. The numerical benchmark uses 139 same industry companies from the supplied master-data set.

BIOPOL CHEMICALS LIMITED (BIOPOL-SM) has a P/E ratio of 11.71x, which is below the benchmark median of 18.07x, a difference of -35.2%. The benchmark contains 139 companies with P/E data, ranging from 0x to 890.11x. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

BIOPOL CHEMICALS LIMITED (BIOPOL-SM) has a ROE of 13.92%, which is above the benchmark median of 12.43%, a difference of +11.99%. BIOPOL CHEMICALS LIMITED (BIOPOL-SM) has a ROCE of 14.37%, which is below the benchmark median of 14.92%, a difference of -3.69%.

Track today's top gainers through the Univest top gainers screener. The peer table below provides the company-level comparison.

BIOPOL CHEMICALS LIMITED operates within the Chemicals sector, which comprises 139 companies in the same industry. The company's P/E ratio of 11.71 is significantly below the industry average of 48.83, positioning it as a potentially attractive investment in terms of earnings valuation. The P/B ratio of 2.11 is above the industry average of 2.49, indicating a higher valuation based on book value.

In terms of profitability, BIOPOL CHEMICALS LIMITED's ROE of 13.92% is above the industry median of 12.43%, while its ROCE of 14.37% is slightly below the industry median of 14.92%. These figures suggest that the company is performing well in terms of equity returns but has room for improvement in capital efficiency.

The Chemicals sector's market capitalisation ranges from Rs 3.49 crore to Rs 3,031.84 crore, with BIOPOL CHEMICALS LIMITED's market cap of Rs 105.14 crore placing it in the lower quartile. This positioning within the sector highlights the company's potential for growth and market expansion.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Hindcon Chemicals Ltd.	HINDCON	104.99	32.89	1.78	14.08	18.92
Archit Organosys Ltd.	ARCHITORG	109.95	14.37	1.51	13.67	11.52
Vital Chemtech Ltd.	VITAL-BE	112.09	107.28	1.11	54.03	21.75
Ambani Orgochem Ltd.	AMBANIORGO-SM	97.18	72.85	1.97	9.63	12.62
Paragon Fine And Speciality Chemical Ltd.	PARAGON-SM	95.87	10.6	1.07	55.3	22.94

BIOPOL CHEMICALS LIMITED (BIOPOL-SM) has a P/E ratio of 11.71x compared with the displayed peer median of 32.89x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 13.92% compares with a peer median of 14.08% across the companies shown in the table. ROCE stood at 14.37% versus the displayed peer median of 18.92%, providing a capital-efficiency comparison. BIOPOL CHEMICALS LIMITED (BIOPOL-SM) has a market capitalisation of Rs 105.14 crore. Among the 5 peers shown, 2 have a larger market capitalisation.

In comparison to its peers, BIOPOL CHEMICALS LIMITED exhibits a competitive edge in certain areas. The company's P/E ratio of 11.71 is lower than Hindcon Chemicals Ltd.'s 32.89 and Ambani Orgochem Ltd.'s 72.85, suggesting a more attractive valuation. However, it is higher than Paragon Fine And Speciality Chemical Ltd.'s 10.6.

In terms of profitability, BIOPOL CHEMICALS LIMITED's ROE of 13.92% is comparable to Archit Organosys Ltd.'s 13.67% and slightly below Hindcon Chemicals Ltd.'s 14.08%. The company's ROCE of 14.37% is lower than Vital Chemtech Ltd.'s 21.75% but higher than Ambani Orgochem Ltd.'s 12.62%.

These comparisons highlight BIOPOL CHEMICALS LIMITED's relative strengths and areas for improvement within the Chemicals sector, offering insights into its market positioning and potential growth trajectory.

Why Investors Are Watching BIOPOL CHEMICALS LIMITED

Investors are closely monitoring BIOPOL CHEMICALS LIMITED due to its recent price surge and competitive fundamentals. The company's attractive P/E ratio and solid ROE make it a noteworthy contender in the Chemicals sector.

• Price Action: 12.54% rise to Rs 109.5, exceeding the micro cap threshold.
• Technical Position: Strong market interest with significant volume.
• Fundamental Context: Competitive P/E and ROE metrics.
• Sector Positioning: Positioned in the lower quartile with growth potential.

As the market continues to evolve, investors should keep an eye on BIOPOL CHEMICALS LIMITED's performance and any developments within the Chemicals sector that may impact its valuation and growth prospects.

About BIOPOL CHEMICALS LIMITED

BIOPOL CHEMICALS LIMITED operates in the Chemicals sector, focusing on the production and distribution of chemical products. The company is involved in various segments within the industry, catering to diverse market needs. With a strong emphasis on innovation and quality, BIOPOL CHEMICALS LIMITED aims to deliver value to its customers and stakeholders.

The company's revenue mix includes a range of chemical products, positioning it as a key player in the industry. As part of the broader Chemicals sector, BIOPOL CHEMICALS LIMITED benefits from industry trends and opportunities for growth. Its strategic initiatives and market presence contribute to its competitive advantage and potential for expansion.

Track BIOPOL CHEMICALS LIMITED Share Price on Univest

Use BIOPOL CHEMICALS LIMITED (BIOPOL-SM) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top gainers lists and related market analysis.

Investors and market enthusiasts can track BIOPOL CHEMICALS LIMITED Share Price on Univest for real-time updates and insights. Univest provides comprehensive data on share price movements, technical indicators, fundamental ratios, and shareholding patterns. Stay informed about the latest market trends and developments to make well-informed investment decisions.

Frequently Asked Questions

How much did BIOPOL CHEMICALS LIMITED's share price rise today?

Ans. The share price of BIOPOL CHEMICALS LIMITED rose by 12.54% today, reaching a closing price of Rs 109.5. The stock moved 12.54% during the session. The intraday range extended from Rs 95.5 to Rs 109.95.

What is the market capitalisation of BIOPOL CHEMICALS LIMITED?

Ans. BIOPOL CHEMICALS LIMITED has a market capitalisation of Rs 105.14 crore, placing it in the micro cap category within the Chemicals sector. The company operates in the Chemicals sector. Its P/E ratio is 11.71x.

What is BIOPOL CHEMICALS LIMITED's P/E ratio?

Ans. BIOPOL CHEMICALS LIMITED's P/E ratio is 11.71, which is below the industry median of 18.07, indicating a potentially undervalued position. The company trades at a P/E ratio of 11.71x. Its P/B ratio is 2.11x.

How does BIOPOL CHEMICALS LIMITED's ROE compare to the industry?

Ans. BIOPOL CHEMICALS LIMITED's ROE is 13.92%, slightly above the industry median of 12.43%, reflecting efficient use of shareholder funds. ROE stands at 13.92%. ROCE stands at 14.37%. The relevant peer median ROE is 12.43%.

What is the industry average P/E ratio for the Chemicals sector?

Ans. The industry average P/E ratio for the Chemicals sector is 48.83, with BIOPOL CHEMICALS LIMITED's P/E ratio being 11.71. The company trades at a P/E ratio of 11.71x. Its P/B ratio is 2.11x.

How does BIOPOL CHEMICALS LIMITED's P/B ratio compare to the industry?

Ans. BIOPOL CHEMICALS LIMITED's P/B ratio is 2.11, which is above the industry median of 1.58, indicating a higher valuation on a book value basis. The company trades at a P/E ratio of 11.71x.